Ari Sedigh

Field CEO Huma

Last Reviewed: September 26, 2026

Executive Summary

Ari Sedigh is Field CEO at Huma, the London health technology company that describes itself as the operating system for AI in regulated industries, with healthcare as its principal market. He is one of the people Huma puts forward in public: in November 2025 he appeared alongside founder and CEO Dan Vahdat before the House of Commons Science, Innovation and Technology Committee, and he is listed as a Huma speaker at the Digital Health World Congress 2026 in London. His conference biography describes a background in information security and DevSecOps and a focus on accelerating the adoption of digital tools and AI across care and research.

Career Highlights

• Field CEO at Huma (Huma Therapeutics), as recorded in the UK Parliament witness list of 19 November 2025.
• Gave oral evidence to the Commons Science, Innovation and Technology Committee in its Innovation showcase inquiry, alongside Huma founder and CEO Dan Vahdat and Huma director Dr Arvind Madan.
• Listed as a speaker for Huma at the Digital Health World Congress 2026 in London.
• Background in information security and DevSecOps, according to his conference biography.

Professional Journey

Little of Sedigh’s career before Huma is on the public record outside scraped profiles, and none of it is recorded here. What the primary sources establish is his current position and the settings in which Huma has chosen to field him.

Huma was founded in 2011 with roots at Johns Hopkins University and the University of Oxford. It is headquartered at Millbank Tower in Westminster, with offices in San Francisco, New York and Frankfurt, and reports around 500 staff and $250 million raised. It now positions itself as infrastructure for deploying AI in regulated industries, with healthcare the principal market. The company completed a Series D of more than $80 million in July 2024, acquired eConsult that October, and in May 2025 announced a partnership with Eckuity Capital together with the acquisition of Aluna.

Sedigh holds the title Field CEO. Huma does not describe the role on its own site, where Dan Vahdat is the only named leader, so its remit is not established; it is distinct from the company’s chief executive. On 19 November 2025 he was one of three Huma Therapeutics witnesses at an oral evidence session of the Commons Science, Innovation and Technology Committee, held in the Palace of Westminster as part of the committee’s Innovation showcase inquiry. He has also been announced as a speaker for Huma at the Digital Health World Congress 2026 in London, whose programme describes him as results-driven and focused on accelerating the adoption of digital and AI across care and research, with a background in information security and DevSecOps.

Education

No education record was found in any primary or first-party source.